CHICAGO TRUST Co NA Sells 31,240 Shares of CME Group Inc. (NASDAQ:CME)

CHICAGO TRUST Co NA lessened its holdings in CME Group Inc. (NASDAQ:CME) by 93.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,294 shares of the financial services provider’s stock after selling 31,240 shares during the quarter. CHICAGO TRUST Co NA’s holdings in CME Group were worth $451,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. B. Riley Wealth Advisors Inc. boosted its stake in shares of CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after purchasing an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC lifted its position in CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares in the last quarter. Lantz Financial LLC lifted its position in CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after buying an additional 49 shares in the last quarter. Transcend Capital Advisors LLC lifted its position in CME Group by 1.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after buying an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC lifted its position in CME Group by 1.6% during the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after buying an additional 52 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME stock traded up $1.51 during trading hours on Friday, hitting $206.66. 1,011,306 shares of the stock were exchanged, compared to its average volume of 1,974,399. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $74.41 billion, a P/E ratio of 23.51, a P/E/G ratio of 6.27 and a beta of 0.52. The company has a 50-day simple moving average of $197.97 and a two-hundred day simple moving average of $206.97. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business earned $2.30 EPS. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, analysts forecast that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Analysts Set New Price Targets

CME has been the topic of several research reports. Barclays upped their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Piper Sandler reduced their price target on shares of CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a research report on Thursday, July 25th. Rosenblatt Securities restated a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Finally, Bank of America upped their target price on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $212.64.

Insider Buying and Selling

In other CME Group news, Director Terry L. Savage sold 2,500 shares of CME Group stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now owns 17,441 shares in the company, valued at $3,673,946.65. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Terry L. Savage sold 2,500 shares of CME Group stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $210.65, for a total value of $526,625.00. Following the sale, the director now directly owns 17,441 shares in the company, valued at $3,673,946.65. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,150 shares of company stock worth $1,455,401. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.